Explore drug information in your own words.
Type a question in the search bar above to get started. Each question is answered independently.
Select a question to fill the search bar, then submit it or edit it first.
AI can make mistakes. Verify answers against the original sources before relying on them.
| Stem definition | Drug id | CAS RN |
|---|---|---|
| analogues of penicillanic acid antibiotics modified in the five-membered ring | 2574 | 161715-24-8 |
| Dose | Unit | Route |
|---|---|---|
| 0.56 | g | O |
None
| Property | Description | Value | Unit | Confidence | Similarity |
|---|---|---|---|---|---|
| azlogd74 | LogD at pH 7.4 | 1.864 | High | 1 | |
| caco2-efflux | Caco-2 efflux ratio (BA/AB) | 7.656 | High | 1 | |
| caco2-intrinsic-papp | Caco-2 intrinsic apparent permeability | 4.457 | 10^-6 cm/s | High | 1 |
| dh-clint | Dog hepatocyte intrinsic clearance | 52.240 | uL/min/10^6 cells | High | 1 |
| dppb | Dog plasma protein binding (% unbound) | 14.120 | % | High | 1 |
| fcs-ppb | Fetal calf serum protein binding (% unbound) | 16.470 | % | High | 1 |
| herg | hERG pIC50 | 4.876 | pIC50 | High | 1 |
| hh-clint | Human hepatocyte intrinsic clearance | 203.704 | uL/min/10^6 cells | High | 1 |
| hlm-clint | Human liver microsomal intrinsic clearance | 299.226 | uL/min/mg protein | High | 1 |
| hppb | Human plasma protein binding (% unbound) | 9.560 | % | High | 1 |
| kinase-safety-class | ACVR2A,ACVR2B,AKT2,AURKA,AXL,BRAF,BTK,CAMK2B,CAMK2D,CDK5,CDK9,DDR1,DYRK1B,EIF2AK3,EPHB4,ERBB2,GRK2,GSK3B,IGF1R,ITK,JAK2,JAK3,MAP2K6,MAP3K21,MAP3K7,MAPK10,MAPK7,MAPK9,MAPKAPK2,MET,MTOR,NTRK2,PDK1,PDK2,PDK4,PDPK1,PIK3CA,PIK3CB,PIK3CD,PIM2,PRKDC,SIK2,STK33,SYK,TEK,TTK,ZAP70 | 47 | |||
| kinase-selectivity-class | AXL,GRK2,PDK1 | 3 | |||
| mdck-mdr1-efflux | MDCK-MDR1 efflux ratio | 16.749 | High | 1 | |
| mh-clint | Mouse hepatocyte intrinsic clearance | 432.514 | High | 1 | |
| mppb | Mouse plasma protein binding (% unbound) | 15.370 | High | 1 | |
| nih-mdck-mdr1-efflux | NIH MDCK-MDR1 efflux ratio | 27.925 | High | 1 | |
| pfas-class | PFAS structural alert (1 = True, 0 = False) | 0 | |||
| pppb | Pig plasma protein binding (% unbound) | 25.130 | % | High | 1 |
| rh-clint | Rat hepatocyte intrinsic clearance | 397.192 | uL/min/10^6 cells | High | 1 |
| rh-fuinc | Rat hepatocyte fraction unbound in incubation | 68.680 | % | High | 1 |
| rppb | Rat plasma protein binding (% unbound) | 14.570 | % | High | 1 |
| solubility-dd | Solubility at pH 7.4 in DMSO | 130.017 | uM | High | 1 |
None
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | J01DH06 | ANTIINFECTIVES FOR SYSTEMIC USE ANTIBACTERIALS FOR SYSTEMIC USE OTHER BETA-LACTAM ANTIBACTERIALS Carbapenems |
| CHEBI has role | CHEBI:33282 | antibacterial agent |
| CHEBI has role | CHEBI:35441 | antiinfective agent |
| CHEBI has role | CHEBI:231911 | renoprotective agent |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.8 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| Prolyl endopeptidase FAP | Enzyme | Ki | 6.19 | CHEMBL |
| ID | Source |
|---|---|
| D09598 | KEGG_DRUG |
| C2699902 | UMLSCUI |
| CHEBI:135799 | CHEBI |
| 1TE | PDB_CHEM_ID |
| CHEMBL2107486 | ChEMBL_ID |
| DB16840 | DRUGBANK_ID |
| C120999 | MESH_SUPPLEMENTAL_RECORD_UI |
| 10864 | IUPHAR_LIGAND_ID |
| 7924 | INN_ID |
| 95AK1A52I8 | UNII |
| 9892071 | PUBCHEM_CID |
| C1568612 | UMLSCUI |
| CHEMBL576981 | ChEMBL_ID |
| 161715-21-5 | SECONDARY_CAS_RN |
| 9800194 | PUBCHEM_CID |
| C500135 | MESH_SUPPLEMENTAL_RECORD_UI |
| Q2TWQ1I31U | UNII |
| CHEBI:749078 | CHEBI |
None